Technologies for deriving primary tumor cells for use in personalized cancer therapy
Technologies for deriving primary tumor cells for use in personalized cancer therapy
About this item
Full title
Author / Creator
Publisher
Cambridge, MA: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Cambridge, MA: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlights • Immortalized cancer cell lines cannot meet the needs of personalized medicine. • Primary cells from solid tumors are important in personalized cancer therapy. • We present pros and cons of different methods for primary tumor cell culture.
Alternative Titles
Full title
Technologies for deriving primary tumor cells for use in personalized cancer therapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3665643
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3665643
Other Identifiers
ISSN
0167-7799
E-ISSN
1879-3096
DOI
10.1016/j.tibtech.2013.03.006
